Your session is about to expire
← Back to Search
Poly-phenylpropanoid-polysaccharide complex
capsule for Allergic Rhinitis (PCE Trial)
N/A
Waitlist Available
Led By Dennis Ledford, M.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
PCE Trial Summary
This trial will test whether a pinecone extract can reduce IgE levels in adults with perennial rhinitis, a condition characterized by chronic inflammation of the nose.
Eligible Conditions
- Allergic Rhinitis
PCE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Objective ( total serum IgE)
PCE Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: capsuleActive Control1 Intervention
patinets receiveing pine cone extract tablets
Group II: placebo capsulePlacebo Group1 Intervention
patinets receiving placebo
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
413 Previous Clinical Trials
188,231 Total Patients Enrolled
Dennis Ledford, M.D.Principal InvestigatorDivision of Allergy and Immunology, USF
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have year-round allergy symptoms with or without seasonal allergies.You need to be at least 18 years old to participate.
Research Study Groups:
This trial has the following groups:- Group 1: placebo capsule
- Group 2: capsule
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies in this research endeavor for participants?
"According to clinicaltrials.gov, this study is no longer actively seeking participants as it was last updated on November 14th 2022. However, there are 62 other studies that still require patients at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger